These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32972570)

  • 1. The Impact of CHA
    Tarantini G; D'Amico G; Schmidt B; Mazzone P; Berti S; Fischer S; Lund J; Montorfano M; Della Bella P; Lam SCC; Cruz-Gonzalez I; Gage R; Zhao H; Omran H; Odenstedt J; Nielsen-Kudsk JE
    JACC Cardiovasc Interv; 2020 Sep; 13(18):2099-2108. PubMed ID: 32972570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study.
    Hildick-Smith D; Landmesser U; Camm AJ; Diener HC; Paul V; Schmidt B; Settergren M; Teiger E; Nielsen-Kudsk JE; Tondo C
    Eur Heart J; 2020 Aug; 41(30):2894-2901. PubMed ID: 32243499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer™ Amulet™ Occluder Observational Study.
    Freixa X; Schmidt B; Mazzone P; Berti S; Fischer S; Lund J; Montorfano M; Della Bella P; Lam SCC; Cruz-Gonzalez I; Gage R; Omran H; Tarantini G; Aminian A; Nielsen-Kudsk JE
    Europace; 2021 Feb; 23(2):238-246. PubMed ID: 33279979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry.
    Landmesser U; Tondo C; Camm J; Diener HC; Paul V; Schmidt B; Settergren M; Teiger E; Nielsen-Kudsk JE; Hildick-Smith D
    EuroIntervention; 2018 Aug; 14(5):e590-e597. PubMed ID: 29806820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study.
    Landmesser U; Schmidt B; Nielsen-Kudsk JE; Lam SCC; Park JW; Tarantini G; Cruz-Gonzalez I; Geist V; Della Bella P; Colombo A; Zeus T; Omran H; Piorkowski C; Lund J; Tondo C; Hildick-Smith D
    EuroIntervention; 2017 Sep; 13(7):867-876. PubMed ID: 28649053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial).
    Lakkireddy D; Windecker S; Thaler D; Søndergaard L; Carroll J; Gold MR; Guo H; Brunner KJ; Hermiller JB; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; Levine J
    Am Heart J; 2019 May; 211():45-53. PubMed ID: 30831333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the CHA
    Agudelo V; Millán X; Li CH; Asmarats L; Fernández-Peregrina E; Santaló M; Jimenez-Kockar M; Gheorghe L; Serra A; Arzamendi D
    Int J Cardiol; 2020 Nov; 319():78-84. PubMed ID: 32634500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
    Lempereur M; Aminian A; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Cruz-Gonzalez I; Kanagaratnam P; Nietlispach F; Ibrahim R; Sievert H; Schillinger W; Park JW; Gloekler S; Tzikas A
    Am J Cardiol; 2017 Aug; 120(3):414-420. PubMed ID: 28595859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure.
    Kleinecke C; Cheikh-Ibrahim M; Schnupp S; Fankhauser M; Nietlispach F; Park JW; Brachmann J; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E324-E331. PubMed ID: 31631493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.
    Kleinecke C; Park JW; Gödde M; Zintl K; Schnupp S; Brachmann J
    Cardiol J; 2017; 24(2):131-138. PubMed ID: 28198520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device.
    Sedaghat A; Schrickel JW; Andrié R; Schueler R; Nickenig G; Hammerstingl C
    JACC Clin Electrophysiol; 2017 Jan; 3(1):71-75. PubMed ID: 29759698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender difference in left atrial appendage occlusion outcomes: Results from the Amplatzer™ Amulet™ Observational Study.
    De Caterina AR; Nielsen-Kudsk JE; Schmidt B; Mazzone P; Fischer S; Lund J; Montorfano M; Gage R; Lam SCC; Berti S
    Int J Cardiol Heart Vasc; 2021 Aug; 35():100848. PubMed ID: 34381870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device.
    Peyrol M; Cautela J; Salaun E; Miola C; Franceschi F; Thuny F; Pinto J; Laine M; Maximovitch A; Paganelli F; Armero S; Bonello L
    Heart Lung Circ; 2019 Nov; 28(11):1683-1688. PubMed ID: 30301672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug.
    Santoro G; Meucci F; Stolcova M; Rezzaghi M; Mori F; Palmieri C; Paradossi U; Pastormerlo LE; Rosso G; Berti S
    EuroIntervention; 2016 Feb; 11(10):1188-94. PubMed ID: 25354761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.